This mechanism differs fundamentally from stimulant-based diet pills that increase heart rate or metabolism
Science 248, 189194
And then I met Dr
1 DECLARE study design DECLARE was a randomized, double-blind, placebo-controlled, multicenter trial (N=17,160) designed to evaluate the effect of FARXIGA 10 mg compared with placebo on CV outcomes in adults with T2D and either multiple CV risk factors (n=10,186) or eCVD (n=6,974)
For most people, yes, when it is medically appropriate and supervised
Facebook Instagram TikTok Youtube About NBC 6 Our News Standards Submit Tips for Investigations Newsletters Contact Us Xfinity: Internet, TV, streaming, more WTVJ Public Inspection File WTVJ Accessibility WTVJ Employment Information FCC Applications Terms of Service Advertise with us Send Feedback Privacy Policy Your Privacy Choices CA Notice Ad Choices Copyright 2026 NBCUniversal Media, LLC